Roberto Muga
Biographic Data
| ID | 6163150 |
|---|---|
| NAME | Roberto Muga |
| GIVEN NAMES | Roberto |
| FAMILY NAME | Muga |
| SIGNATURE | MUGA R |
| AFFILIATIONS | Hospital Universitari Germans Trias i Pujol |
| ORCID | 0000-0001-6301-431X |
| VERIFIED | Yes |
| TOTAL WORKS | 5 |
| TOTAL CITATIONS | 1 |
| WORKS AS AUTHOR | 5 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2004 |
| LATEST PUBLICATION YEAR | 2023 |
| H-INDEX | 1 |
Sex differences in the comorbidity of patients seeking a first treatment for Alcohol Use Disorder
Background The CohRTA multicenter study aims to characterize patients undergoing a first treatment for alcohol use disorder (AUD). The objective is to analyze sex-specific differences in the comorbidity of AUD when starting the first treatment for the disorder. Methods A multicenter study was carried out between 2014 and 2021 in 6 public centers in Spain. Sociodemographic characteristics were collected, variables related to alcohol consumption, m…
Synthetic cannabinoids use in a sample of opioid-use disorder patients
Cannabis is the most widely consumed illegal drug in the world and synthetic cannabinoids are increasingly gaining popularity and replacing traditional cannabis. These substances are a type of new psychoactive substance that mimics the cannabis effects but often are more severe. Since, people with opioids use disorder use widely cannabis, they are a population vulnerable to use synthetic cannabinoids. In addition, these substances are not detecte…
Association of Opioid Agonist Treatment With All-Cause Mortality and Specific Causes of Death Among People With Opioid Dependence
Importance Mortality among people with opioid dependence is higher than that of the general population. Opioid agonist treatment (OAT) is an effective treatment for opioid dependence; however, there has not yet been a systematic review on the relationship between OAT and specific causes of mortality. Objective To estimate the association of time receiving OAT with mortality. Data Sources The Embase, MEDLINE, and PsycINFO databases were searched t…
Impact of injecting drug use on the interruption of antiretroviral therapies
It has been pointed out that HIV positive patients with a history of drug misuse are less likely to undergo antiretroviral therapy (ART) than those who belong to other categories of transmission.1,2 Moreover, inadequate use of ART in injecting drug users (IDUs) is controversial because of the risk of parenteral and/or sexual transmission of drug resistant HIV variants.3 The aim of this study was to describe the frequency of use and cessation of a…
Gender differences in progression to Aids and death from HIV seroconversion in a cohort of injecting dug users from 1986 to 2001
Background: Although the consensus is that gender does not influence HIV progression, its relevance may depend on the setting. Aim: To study gender differences in HIV progression to AIDS and death from 1986 to 2001 in a cohort of injecting drug user (IDU) seroconverters in Spain. Methods: Risk of AIDS and death in persons infected for the same length of time were compared through Kaplan-Meier, allowing for late entry, and Cox regression adjusting…
Gender differences in progression to Aids and death from HIV seroconversion in a cohort of injecting dug users from 1986 to 2001
Background: Although the consensus is that gender does not influence HIV progression, its relevance may depend on the setting. Aim: To study gender differences in HIV progression to AIDS and death from 1986 to 2001 in a cohort of injecting drug user (IDU) seroconverters in Spain. Methods: Risk of AIDS and death in persons infected for the same length of time were compared through Kaplan-Meier, allowing for late entry, and Cox regression adjusting…
Impact of injecting drug use on the interruption of antiretroviral therapies
It has been pointed out that HIV positive patients with a history of drug misuse are less likely to undergo antiretroviral therapy (ART) than those who belong to other categories of transmission.1,2 Moreover, inadequate use of ART in injecting drug users (IDUs) is controversial because of the risk of parenteral and/or sexual transmission of drug resistant HIV variants.3 The aim of this study was to describe the frequency of use and cessation of a…
Gender differences in progression to Aids and death from HIV seroconversion in a cohort of injecting dug users from 1986 to 2001
Background: Although the consensus is that gender does not influence HIV progression, its relevance may depend on the setting. Aim: To study gender differences in HIV progression to AIDS and death from 1986 to 2001 in a cohort of injecting drug user (IDU) seroconverters in Spain. Methods: Risk of AIDS and death in persons infected for the same length of time were compared through Kaplan-Meier, allowing for late entry, and Cox regression adjusting…
Association of Opioid Agonist Treatment With All-Cause Mortality and Specific Causes of Death Among People With Opioid Dependence
Importance Mortality among people with opioid dependence is higher than that of the general population. Opioid agonist treatment (OAT) is an effective treatment for opioid dependence; however, there has not yet been a systematic review on the relationship between OAT and specific causes of mortality. Objective To estimate the association of time receiving OAT with mortality. Data Sources The Embase, MEDLINE, and PsycINFO databases were searched t…
Synthetic cannabinoids use in a sample of opioid-use disorder patients
Cannabis is the most widely consumed illegal drug in the world and synthetic cannabinoids are increasingly gaining popularity and replacing traditional cannabis. These substances are a type of new psychoactive substance that mimics the cannabis effects but often are more severe. Since, people with opioids use disorder use widely cannabis, they are a population vulnerable to use synthetic cannabinoids. In addition, these substances are not detecte…
Sex differences in the comorbidity of patients seeking a first treatment for Alcohol Use Disorder
Background The CohRTA multicenter study aims to characterize patients undergoing a first treatment for alcohol use disorder (AUD). The objective is to analyze sex-specific differences in the comorbidity of AUD when starting the first treatment for the disorder. Methods A multicenter study was carried out between 2014 and 2021 in 6 public centers in Spain. Sociodemographic characteristics were collected, variables related to alcohol consumption, m…
Medicine (4 works) · Internal Medicine (3 works) · Drug (2 works) · HIV, Drug Use, Sexual Risk (2 works) · Human immunodeficiency virus (HIV) (2 works) · Pharmacology (2 works) · Psychiatry (2 works) · Addiction (1 work) · Alcohol (1 work) · Alcohol Consumption and Health Effects (1 work)